iBio, Inc.IBIONYSE
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -46.06% |
| Q3 2025 | 16.74% |
| Q2 2025 | -21.49% |
| Q1 2025 | -24.16% |
| Q4 2024 | -26.01% |
| Q3 2024 | -16.83% |
| Q2 2024 | -63.07% |
| Q1 2024 | 35.13% |
| Q4 2023 | -55.04% |
| Q3 2023 | -27.23% |
| Q2 2023 | -42.58% |
| Q1 2023 | -31.28% |
| Q4 2022 | -64.91% |
| Q3 2022 | -96.99% |
| Q2 2022 | 1897.57% |
| Q1 2022 | -12.38% |
| Q4 2021 | -9.92% |
| Q3 2021 | -7.41% |
| Q2 2021 | 2.46% |
| Q1 2021 | -14.76% |
| Q4 2020 | 15.80% |
| Q3 2020 | 21.93% |
| Q2 2020 | 716.20% |
| Q1 2020 | 451.52% |
| Q4 2019 | 84.08% |
| Q3 2019 | -171.86% |
| Q2 2019 | -65.70% |
| Q1 2019 | -39.43% |
| Q4 2018 | -18.58% |
| Q3 2018 | -40.61% |
| Q2 2018 | 240.87% |
| Q1 2018 | -55.52% |
| Q4 2017 | 18.01% |
| Q3 2017 | -31.51% |
| Q2 2017 | -31.16% |
| Q1 2017 | -24.48% |
| Q4 2016 | -17.16% |
| Q3 2016 | -13.92% |
| Q2 2016 | 3722.59% |
| Q1 2016 | 177.15% |